Meet Our Team

Zhiwen Jonathan Zhang, Ph.D.
Founder, President, CEO (interim), CTO

Dr. Zhang is known for pioneering work in Chemical Biology, Synthetic Biology and Protein Medicinal Chemistry, particularly on expanding unnatural amino acid genetic codes, computational design of single-chain antibody and biorthogonality theory.

In addition to top-tiered publications, he has authored and co-authored 14 patents, all have been licensed by biopharmaceutical companies. For example, his “Red Code” patent has been wildly used by biopharmaceutical companies to develop and manufacture ADC therapy, as well as PEGlated-protein drugs. His patented technologies have helped founded two successful biopharma companies - Ambrx, Inc. in San Diego and Cloudbreak Pharmaceutical, Inc. in Los Angeles. He has served as technical consultant for several silicon valley biotech companies and VC groups.

Gary Li, Ph.D.
Co-founder, COO
  • Founder, CO of Alstem Inc.
  • Extensive experience on biological product development and production
  • Accomplished research in cell biology and regenerative medicine
Jie Zhu, Ph.D.
Director of Research
  • Director of Biology at BioRay Pharmaceutical
  • Group leader at BPS.
  • PhD in cell biology from University of Texas at Austin
  • Pioneered the study of novel mechanism of sortase A in the cellular environment
Emily Park, Ph.D.
Director of Operations
  • Over 20 years of management experience for biotech R&D
  • Nuvelo, BD Biosciences, and Advanced Cell Diagnostics
  • Ph.D. in Microbiology from the University of Massachusetts.
Huong Chau, Ph.D.
  • 8+ Years Experience in Anti-Infective Drug Discovery Research
  • Ph.D. in Integrative Pathobiology from the University of California, Davis
  • Pioneered the study of the biophysical mechanism between small molecule drug candidate affinity to Sortase A dimer in vitro.
Jeff Chu, MBA
Business development
  • Capital executive director
  • Bank senior manager
  • Risk management partner.


Min Li-Danielsson, MBA, M.Ed.
Co-founder, Advisor
  • Over 20 years executive experience in the Fortune Global 500 companies.
  • As an entrepreneur, won the prestigious national SuperGASELL award in Dagens Industri in 2022
  • President of Minnovation Group AB.
Paul Davison, M.S.
  • Over 30 years experience of VP of R&D and product development in medical industry
  • Successful acquisition of Peak Surgical by Medtronic in 2011
  • IPO of Invuity (IVTY) in 2015.
  • Currently COO for Provisio Medical.
Chao Zhuang, Ph.D.
  • Founder, CEO of EA Therapeutics
  • Over 15 years experience in Biotech
  • Extensive experience on biologics R&D and GMP manufacturing
  • Over 100 million RMB license out